EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Lichen China Limited Class A (LICN) fair value: what the stock is really worth

As of Oct 14, 2026: fair value of Lichen China Limited Class A $1.63, price $0.93, upside +75.5%, quality 38 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Industrials · US · Based in China · ISIN KYG5479G1165

LC Lichen China Limited Class A logo Thin data Oct 3, 2026

Lichen China Limited Class A

LICN · US

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

The stock costs 43% less than our calculation considers fair.

Fair value $1.63 · Strongly undervalued (+75.5%)
Quality 38/100
Weak Growth (revenue 5y −4.4 %/yr in USD)
Loss-making · -117.7% net margin (TTM) · excl. goodwill write-downs -99.9%
Negative free cash flow
Trails peers (3/9)
Narrow moat 8/100 · thin data
Thin data
⚠ Dilution
Watch Lichen China Limited Class A Ordinary Shares for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$948.00 $0.8404 Fair Value $1.63 Feb 2023 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.

How to read this chart

44‑month range $0.8404 – $948.00 · fair‑value band $1.08 – $2.04 · the $0.9300 price screens below the $1.63 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.

Follow Lichen China Limited Class A Ordinary Shares in your weekly email

Every Wednesday you see whether Lichen China Limited Class A Ordinary Shares is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Lichen International Limited, an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China.

Show moreShow less

The company offers financial and taxation-related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education support services, including marketing, operational, and technical support, as well as the sale of teaching and learning materials.

It also provides software and maintenance services, including the sale of financial and taxation analysis software, and financial and taxation training software, as well as offers software installation, training, and after-sales technical and maintenance support services.

The company serves listed companies, state-owned enterprises, government authorities, and other business enterprises, including small and medium-sized enterprises. The company was formerly known as Lichen China Limited and changed its name to Lichen International Limited in March 2025.

Lichen International Limited was incorporated in 2016 and is based in Xiamen, China.

Stock analysis

Lichen China Limited Class A Ordinary Shares (LICN) currently trades at $0.9300, while our model-based Fair Value estimate is $1.63, implying the stock looks roughly 43.0% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.

Scenario range: $1.08 (bear) to $2.04 (bull), the price of $0.9300 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 38/100 (below-average quality), in the Industrials sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Lichen China Limited Class A Ordinary Shares reported revenue of $24.5M in FY2025 versus $34.3M in FY2021, a compound −8.0%/yr. Reported net income was −$22.0M in FY2025.

Key figures

Market cap $15.2M · P/S ratio 0.80 · EPS (TTM) $−4.11 · Net margin −89.6% · Return on equity −38.6% · Return on assets (EBIT) 8.6% · Operating margin −85.0% · Revenue (TTM) $20.5M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).

What moves the price

The share trades about 89% below its 52-week high and 11% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −3% fair-value upside, at 75%, LICN screens cheaper than that median.

Fair Value models

Bear $1.08 Fair Value $1.63 Bull $2.04
Price $0.9300 · Upside +75.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
NCAV (Graham) $2.18 $2.91 $4.35 51
All 1 models by family
Asset-Based
NCAV (Graham) $2.18 $2.91 $4.35 51

Open the full fair value analysis →

Quality Score breakdown

Overall quality 38/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 7
How much profit the company makes from its sales and capital
Quality Growth 0
Are margins and returns getting better?
Cashflow 30
Do the profits arrive as real cash?
Financial strength 94
Debt, balance sheet and risk of trouble
Investment 38
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Momentum 4
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 1
Distance to the 52-week high, does not count
New shares 50
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−40.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−10.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.4%
Start year 2020 (pandemic). Over 10 years: +5.2% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
28.7% (2020) → −58.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch LICN, get fair value alerts →

Compare Lichen China Limited Class A Ordinary Shares with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Business Services · 235 stocks

Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 38 · Bottom 25%
Fair Value upside +75.5% · Top 25%
Profitability
Return on assets −29.1% · Bottom 25%
Net margin (12 months) −117.7% · Bottom 25%
Operating margin (12 months) −85.0% · Bottom 25%
Growth and dividend
Revenue growth −28.0% · Bottom 25%

Valuation Multiplesvs Specialty Business Services median · lower = cheaper

P/B 0.22× · Cheapest 25%
P/S (12 months) 0.74× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 41
FUTURE (revenue growth)0 · sector 31
PAST (return on equity)0 · sector 37
HEALTH (low debt)0 · sector 94
DIVIDEND (yield)0 · sector 50

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Wolters Kluwer N.V WKL €75.00 €98.05 +31% vs LICN
Copart, Inc CPRT $26.48 $31.02 +17% vs LICN
RB Global, Inc RBA C$122.50 C$134.75 +10% vs LICN
Global Payments Inc GPN $82.06 $88.43 +8% vs LICN
Rentokil Initial plc RTO $20.24 $19.63 −3% vs LICN
Brambles Limited BXB A$19.38 A$18.78 −3% vs LICN
Cintas Corporation CTAS $205.23 $188.06 −8% vs LICN
Thomson Reuters Corporation TRI $99.28 $70.79 −29% vs LICN
UL Solutions Inc ULS $69.99 $33.46 −52% vs LICN
Aramark ARMK $54.94 $23.06 −58% vs LICN

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Lichen China Limited Class A Ordinary Shares · Fair Value
$1.63 +43%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Lichen China Limited Class A Ordinary Shares Fair Value". https://www.fairvalue-calculator.com/stock/LICN

Frequently asked questions

Is Lichen China Limited Class A (LICN) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of $1.63 versus a price of $0.9300, about +75% upside (undervalued).
What is the fair value of LICN?
Our model-based fair value for Lichen China Limited Class A Ordinary Shares is $1.63 (as of Oct 3, 2026), built from audited fundamentals. The current price: $0.9300.
What is the quality score of LICN?
Lichen China Limited Class A Ordinary Shares has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Lichen China Limited Class A (LICN)?
Our model-based price target is the fair value of $1.63 (as of Oct 3, 2026) from 1 valuation models. Cautious scenario $1.08, optimistic scenario $2.04. It is a calculation from audited fundamentals, not an analyst target.
What is the Lichen China Limited Class A Ordinary Shares stock forecast for 2026?
Our models put fair value at $1.63, about +75% upside versus a price of $0.9300 (undervalued). Cautious scenario $1.08, optimistic scenario $2.04. The calculation is refreshed regularly with new filings.
What is the revenue of Lichen China Limited Class A (LICN)?
Lichen China Limited Class A Ordinary Shares reported trailing-twelve-month revenue of about $20.5M (latest available figure, as of Oct 3, 2026).
What is the intrinsic value of Lichen China Limited Class A (LICN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Lichen China Limited Class A Ordinary Shares it is $1.63 per share (as of Oct 3, 2026), against a price of $0.9300. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Lichen China Limited Class A Ordinary Shares stock overvalued or undervalued in 2026?
As of Oct 3, 2026, LICN trades below its calculated fair value: price $0.9300, fair value $1.63, a gap of about +75% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of LICN?
No. The price is what the market pays today ($0.9300); the fair value is what the company's own numbers justify ($1.63). For Lichen China Limited Class A Ordinary Shares the two are $0.7020 per share apart. That gap is exactly why we show both numbers side by side.
How much is Lichen China Limited Class A Ordinary Shares worth?
The market values Lichen China Limited Class A Ordinary Shares at about $15.2M (market capitalisation, as of Oct 3, 2026). Per share that is $0.9300; our models calculate a fair value of $1.63 per share.
What do the bullish and bearish scenarios say about LICN?
Our models span a range for Lichen China Limited Class A Ordinary Shares: cautious scenario $1.08, base $1.63, optimistic $2.04 per share (as of Oct 3, 2026, price $0.9300). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Lichen China Limited Class A (LICN)?
Balance-sheet figures for Lichen China Limited Class A Ordinary Shares (as of Oct 3, 2026): return on equity −38.6%. They feed the Quality Score of 38/100, which measures business quality independently of the share price.
How far is LICN from its 52-week high?
Lichen China Limited Class A Ordinary Shares trades at $0.9300, about 89% below its 52-week high of $8.63 and 11% above the low of $0.8404 (as of Oct 14, 2026). Distance from the high says nothing about value: that is what the fair value of $1.63 is for.
Which stocks are comparable to Lichen China Limited Class A Ordinary Shares?
From the same area (Industrials) we also value Cintas Corporation, Thomson Reuters Corporation, Copart, Inc, Global Payments Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Lichen China Limited Class A Ordinary Shares stock attractive at the current price?
The data as of Oct 3, 2026: price $0.9300, calculated fair value $1.63 (+75%), Quality Score 38/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of LICN calculated?
We run Lichen China Limited Class A Ordinary Shares through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $1.63, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.7 % above its aggregate fair value. Lichen China Limited Class A Ordinary Shares currently trades 43 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Lichen China Limited Class A (LICN)?
The closing price on Oct 14, 2026 was $0.9300. Our model-based fair value is $1.63, about +75% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Lichen China Limited Class A Ordinary Shares right now?
The large discount to fair value meets weak quality (38/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($1.08). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($1.08 to $2.04) leaves room in how you read the outcome.
Where does the earnings growth of Lichen China Limited Class A (LICN) come from?
Earnings per share at Lichen China Limited Class A Ordinary Shares grew +16.0 % a year from 2014 to 2024. Broken into its drivers: revenue per share +17.3 %, EBIT margin −0.6 %, tax rate −0.2 %, residual (interest, one-offs) −0.4 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Lichen China Limited Class A Ordinary Shares

How large is the market capitalisation of Lichen China Limited Class A (LICN)?
The market capitalisation of Lichen China Limited Class A Ordinary Shares is $15.2M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Lichen China Limited Class A (LICN)?
The price-to-sales ratio of Lichen China Limited Class A Ordinary Shares is 0.80 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Lichen China Limited Class A (LICN)?
Earnings per share at Lichen China Limited Class A Ordinary Shares are $−4.11. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Lichen China Limited Class A (LICN)?
The net margin of Lichen China Limited Class A Ordinary Shares is −89.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Lichen China Limited Class A (LICN)?
The return on equity (ROE) of Lichen China Limited Class A Ordinary Shares is −38.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Lichen China Limited Class A (LICN)?
On an EBIT basis the return on assets of Lichen China Limited Class A Ordinary Shares is 8.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Lichen China Limited Class A (LICN)?
The operating margin of Lichen China Limited Class A Ordinary Shares is −85.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Lichen China Limited Class A (LICN)?
Revenue at Lichen China Limited Class A Ordinary Shares is growing −28.0% versus a year earlier (3y avg −10.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Lichen China Limited Class A (LICN)?
Earnings per share at Lichen China Limited Class A Ordinary Shares are growing −51.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Lichen China Limited Class A (LICN) generate?
The free cash flow of Lichen China Limited Class A Ordinary Shares is −$17.8M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Lichen China Limited Class A (LICN) hold?
Lichen China Limited Class A Ordinary Shares holds more cash than debt, $26.4M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Lichen China Limited Class A Ordinary Shares in the live analysis

One click puts Lichen China Limited Class A Ordinary Shares on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.